Category: BioTech

Biotech stock market news
BioTech, Finance

Biotech Stocks: Amicus Therapeutics (FOLD) Soars High After Positive Results

Shares of Amicus Therapeutics (FOLD) soared 20.4% after the company announced positive data from its second phase III study (Study 012) on the oral small molecule chaperone migalastat HCl in Fabry patients with amenable mutations. The phase III study is evaluating the use of oral migalastat to standard-of-care enzyme replacement therapies (ERTs) − Sanofi’s (SNY) Fabrazyme and Shire’s (SHPG) Replagal − for Fabry disease. Eighteen-month … Continue reading Biotech Stocks: Amicus Therapeutics (FOLD) Soars High After Positive Results

Richard Atkins
Analysis, BioTech, Commodities, Diversified Tech, Finance, Mergers & Acquisitions, Semiconductors, Services Sector, Software, Tech IPO, Venture Capital

Autoliv Reports 1Q Results, Beats Street Consensus by $0.09; Maintaining our $80 FVE

No-moat, positive-moat-trend rated Autoliv ALV reported first-quarter earnings per share before special items of $1.32, $0.09 ahead of the Street consensus of $1.23. Even so, owing to lackluster European new-car demand and Autoliv’s European customers’ inventory corrections, the $1.32 first-quarter EPS were down $0.24 from $1.56 a year ago. However, management favorably tweaked its full-year 2013 guidance, slightly raising its expectations for revenue growth of … Continue reading Autoliv Reports 1Q Results, Beats Street Consensus by $0.09; Maintaining our $80 FVE

John MeadyLeave a comment
BioTech, Finance

Biotech Stocks: The Consequences of Intermune Takeover

Roche’s (RHHBY) $8.3 billion deal, announced over the weekend, to take over biotech firm InterMune (ITMN) triggered significant stock price appreciation in many mid-cap firms in the space on Aug 25. Switzerland-based Roche is looking to strengthen its respiratory portfolio through the impending InterMune buy. The offer price of $74.00 per share represents a premium of 37.5% to InterMune’s closing price on Aug 22, 2014. … Continue reading Biotech Stocks: The Consequences of Intermune Takeover

Richard Atkins
BioTech

Biotech Stock Report: Reviewing InterMune, Advaxis, Inc & Amgen, Inc

Here in this article, we take a good look at three upcoming Biotech Stocks, namely, InterMune, Advaxis, Inc & Amgen, Inc. InterMune Inc (NASDAQ ITMN) listed its shares as a big mover previous session, as its shares jumped over 35% after Roche AG’s declaration it would buy the respiratory-drug maker for $8.3B, in spite of InterMune’s relatively small array of drugs in its pipeline. According … Continue reading Biotech Stock Report: Reviewing InterMune, Advaxis, Inc & Amgen, Inc

Richard Atkins
Analysis, BioTech, Commodities, Diversified Tech, Finance, Mergers & Acquisitions, Semiconductors, Services Sector, Software, Tech IPO, Venture Capital

SBA Beats Expectations, Raises Guidance Once Again in the First Quarter

SBA Communications SBAC notched another strong firstquarter result, highlighted by better-than-expected earnings and another guidance upgrade. First-quarter revenues grew by 62% year over year to $313 million–roughly 4% above consensus. The growth was driven by a 64.1% increase in the firm’s tower base, which now stands at 17,539. Once again, however, SBA’s growth was in both quality and quantity. The firm was able to expand … Continue reading SBA Beats Expectations, Raises Guidance Once Again in the First Quarter

John MeadyLeave a comment
Analysis, BioTech, Commodities, Diversified Tech, Finance, Mergers & Acquisitions, Semiconductors, Services Sector, Software, Tech IPO, Venture Capital

Sohu Posts Solid First-Quarter Results on Strong Top-Line Growth Across All Segments

Chinese Internet firm Sohu SOHU posted first-quarter revenue and earnings that slightly exceeded the firm’s guidance and our internal estimate, thanks to solid top-line growth across brand advertising, search, and gaming. Revenue grew by 36% year over year to $308 million (versus $299 million at the high end of guidance), while non-GAAP net income came in at $24 million (versus $21 million at the high … Continue reading Sohu Posts Solid First-Quarter Results on Strong Top-Line Growth Across All Segments

John MeadyLeave a comment